Skip to content
Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today episode artwork

Jul 17, 2024 29 min

Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

from Keeping Current

Clinical trials have reshaped multidisciplinary treatment paradigms for early-stage disease. Is your clinic up to date? Credit available for this activity expires: 7/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001332?ecd=bdc_podcast_libsyn_mscpedu

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

0:00 29:49

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Keeping Current?

This episode is 29 minutes long.

When was this Keeping Current episode published?

This episode was published on July 17, 2024.

Can I download this Keeping Current episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.